Castle Biosciences Inc (CSTL) — Cash Flow Quality Index
Castle Biosciences Inc (CSTL) has a Cash Flow Quality Index of 4.60x as of June 2025. Operating cash flow of $20.82 Million exceeds net income of $4.52 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Castle Biosciences Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Castle Biosciences Inc Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Castle Biosciences Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see CSTL cash flow metrics.
Annual Cash Flow Quality Index for Castle Biosciences Inc (2019–2024)
Year-by-year earnings quality comparison for Castle Biosciences Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 3.56x | $64.87 Million | $18.25 Million | ▲ +167.4% |
| 2019 | 1.33x | $7.01 Million | $5.28 Million | — |